Elsevier B.V
1879-1484
Monthly
4.9
0021-9150
1970
31204853911
Netherlands The
English
YES
Google Scholar
arnold.voneckardstein@usz.ch
Cardiovascular disease (CVD) causes one third of all deaths worldwide and is a major threat to global health. Atherosclerosis aims to provide a comprehensive platform for researchers, clinicians and healthcare professionals to share the latest findings and advances in the field of atherosclerosis. Atherosclerosis covers a wide range of topics, including: Pathophysiology and Mechanisms: We explore the intricate cellular and molecular processes involved in atherogenesis, from the initial formation of fatty streaks to the development of complex plaques. We also welcome studies on cardiac biology and disease. Risk Factors: We consider manuscripts that examine both traditional and emerging risk factors for atherosclerosis, such as dyslipidaemia, hypertension, diabetes mellitus, thrombosis and genetic predisposition. Prevention of CVD: Since prevention will become a major focus in the future (see e.g. the European Cardiovascular Health Plan), an important focus will be on preventive strategies, including lifestyle modifications and pharmacological interventions. Diagnostics Techniques: We features articles on cutting-edge diagnostic techniques, ranging from invasive procedures such as selective coronary arteriography to non-invasive techniques such as blood biomarkers. Treatment Approaches: Atherosclerosis covers the latest developments in the treatment of atherosclerosis, including lipid-lowering therapies, anti-inflammatory treatments and novel targeted approaches aimed at modifying disease progression and improving clinical outcomes. Translational Research: We bridges the gap between basic science and clinical practice by highlighting translational studies that bring laboratory findings closer to practical applications in patient care. By fostering collaboration and knowledge exchange between researchers and clinicians, Atherosclerosis aims to accelerate progress in the understanding, prevention and treatment of atherosclerosis, ultimately improving the lives of the millions of people affected by this pervasive disease.
Genetic variation in the apolipoprotein E (APOE) gene is a significant determinant of variation in plasma cholesterol levels and it also affects the risk of coronary artery disease (CAD). We...
Myocardial ischemia with no obstructive coronary arteries (INOCA) is a chronic coronary syndrome condition that is increasingly being recognized as a substantial contributor to adverse cardi...
Aims We sought to investigate the hypothesis that smoking is accompanied by systemic inflammation. Methods and results We examined the relation of smoking to 11 systemic inflammatory mark...
OJSCloud offers a complete, free setup to get you publishing.
Start Your Free Journal!Scholar9.com is a peer-review platform that hosts journals from across the globe. Please note that we do not own any of the journals hosted on the platform.
Our platform enables journal owners to send articles for peer review to users who have registered via https://scholar9.com/register and have consented to serve as reviewers for multiple journals. Additionally, we offer an indirect manuscript submission system for journals that are claimed and actively managed by their respective owners on Scholar9.com.
For accurate information about the indexing status of journals (in databases such as UGC CARE, Scopus, or Web of Science) and contact details, users must refer to the respective official websites.
Scholar9 is not responsible for indexing claims, manuscript acceptance/rejection, refunds of article processing charges, or any stage of the final publication process. Users are strongly advised to verify all information provided on the platform independently.
Scholar9.com disclaims liability for disputes related to indexing claims, publication decisions, or other journal-specific matters. Users are encouraged to contact the respective journal owners directly for detailed information and clarifications.